GENEVA, July 2 -- AMGEN INC. filed a patent application (US2025/058022) for “BIOLOGICAL DETECTION SYSTEMS AND METHODS FOR SETTING MEDICALLY SUITABLE TARGET RANGES OF ATTRIBUTES USING PRINCIPAL COMPONENT ANALYSIS (PCA)”. With publication no. WO/2026/135998, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 40/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....